HIRA

상급종합병원 경증질환자 의료이용 분석 및 효과평가 연구

  • 316
  • 180
Metadata Downloads
Type
Research report
Author(s)
김상현김명화김록영장준전인혜
Issued Date
2022-01
Keyword
경증질환정책효과의료전달체계Mild Diseases PatientsHealthcare Delivery SystemHealthcare UtilizationInterrupted Time SeriesHealth Insurance Review & Assessmet
Abstract
Background: The purpose of this study is to analyze the healthcare utilization and policy effects for mild diseases patients in tertiary hospital. In 2011, The Ministry of Health and Welfare come up with the plan for redefining role of medical institutions for the establishment of healthcare delivery systems. The government have instituted several policy such as increase in coinsurance rate for outpatients at tertiary hospital, differential coinsurance policy on prescription drug coverage in an effort to improve patient’s concentrations problem on tertiary hospital.
Methods: This study used a National Health Insurance Claims Data, collected by Health Insurance Review and Assessment(HIRA) from 2008 to 2020, and we analyzed healthcare utilization for mild diseases patients over a long period. We classified mild diseases characteristics as chronic and non-chronic diseases, and analyzed trend of healthcare utilization depending on its characteristics. The short-term effects is identified by comparing for 1 year before and after intervention. And we analyze the long-term effects using Interrupted Time Series analysis.
Results: In the chronic and non-chronic mild diseases, the number of visits and portions of mild diseases outpatients who visited tertiary hospital decreased by before and after interventions. However, hospitalizations and emergency room visits have increased or remained unchanged since the policies. We showed that differential coinsurance policy on prescription drug coverage among policies aimed at improving healthcare systems was an immediate drop in the portions of mild diseases outpatients. In addition to the policy to control demand, the second tertiary hospitals designation system, which controled supply, showed a long-term effects of continuously decreasing the proportions of outpatients with mild diseases.
Discussion: Afrer differential coinsurance policy on prescription drug coverage, the healthcare utilization of outpatients with mild diseases have increased in clinics, but similarly in hospitals. Therefore, starting with primary care, it is necessary to improve the healthcare delivery systems so that referrals requests can be made step by step to upper medical institutions. We analyzed the healthcare utilization of outpatients with mild diseases using Interrupted Time Series. The result showed that the healthcare utilization of outpatients with mild diseases and multimorbidity have decreased even more. We consider that the government should build the management of chronic diseases for outpatients with chronic mild diseases and multimorbidity to improve policy effects.
Publisher
건강보험심사평가원
URI
https://repository.hira.or.kr/handle/2019.oak/3044
Alternative Title
Analysis of the healthcare utilization for mild diseases patients and study on policy effects in tertiary hospital
Table Of Contents
요 약 ⅰ

제1장 서 론 ···································································································· 1
1. 연구 배경 ······································································································ 1
2. 연구 목적 ······································································································ 4
3. 주요 연구 내용 ···························································································· 4

제2장 이론적 고찰 ························································································· 7
1. 제도 고찰 ······································································································ 7
가. 의료전달체계 재정립 관련 정책 ························································· 7
나. 상급종합병원 외래 본인부담률 인상 ·················································· 8
다. 경증질환 약제비 본인부담률 차등제 ················································ 10
라. 상급종합병원 지정 기준 ···································································· 13
2. 선행연구 검토 ···························································································· 15
가. 상급종합병원 외래 본인부담률 인상 ················································ 15
나. 경증질환 약제비 본인부담률 차등제 ················································ 17
다. 상급종합병원 지정 기준 ···································································· 19
라. 본인부담과 의료이용 ·········································································· 19
3. 시사점 ········································································································· 20

제3장 의료이용 현황 및 효과 분석 ···························································· 21
1. 분석 개요 ···································································································· 21
가. 분석 틀 ································································································ 21
나. 분석 대상 및 정의 ············································································· 22
2. 경증질환자 의료이용 현황 ······································································· 32
가. 연도별 경증질환자 의료이용 현황 ··················································· 32
나. 연도별 만성 경증질환자 의료이용 현황 ·········································· 35
3. 정책효과 분석 ···························································································· 38
가. 환자 수 비율 및 환자당 방문횟수 분석 ·········································· 38
나. 신규 경증질환자 분석 ········································································ 51
다. 이용경로 분석 ····················································································· 52
라. 입원율 및 응급실 방문율 분석 ························································· 56

제4장 정책의 장기효과 평가 ······································································· 59
1. 분석 개요 ···································································································· 59
가. 단절적 시계열 분석(Interrupted Time Series Analysis: ITS) 59
나. 자료 구축 ····························································································· 60
2. 분석 방법 ···································································································· 61
가. 모형 설정 ····························································································· 61
나. 변수 설명 ····························································································· 62
3. 분석 결과 ···································································································· 63
가. 상급종합병원 경증질환 정책 효과 ··················································· 63
나. 상급종합병원 만성 및 만성 외 경증질환 정책 효과 ····················· 66
다. 상급종합병원 복합만성질환자 경증질환 정책 효과 ······················· 72
라. 상급종합병원 중증도별 경증질환 정책 효과 ·································· 78

제5장 논의 및 결론 ····················································································· 85
1. 상급종합병원 경증질환자 의료이용 및 정책효과 분석 결과 ··············· 85
가. 의료이용 현황 및 정책효과 분석 ····················································· 85
나. 정책의 장기효과 평가: 시계열 분석 ················································ 87
2. 제언 ············································································································· 87
3. 제한점 ········································································································· 89

참고문헌 ········································································································ 91
ABSTRACT ·································································································· 95
부 록 ··········································································································· 97
Publisher
건강보험심사평가원
Location
KOR
Citation
김상현 et al. (202201). 상급종합병원 경증질환자 의료이용 분석 및 효과평가 연구.
Appears in Collections:
HIRA 연구 > 1. 자체연구
Authorize & License
  • Authorize공개
Files in This Item:

열람하신 정보에 대해 만족하십니까?

Comment

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.